Literature DB >> 18405444

Time to treatment of prostate cancer through the Calgary Prostate Institute rapid access clinic.

Alex G Kavanagh1, Jay C Lee, Bryan Donnelly.   

Abstract

PURPOSE: To determine the wait time between initial referral, biopsy, diagnosis and individual treatment modalities of prostate cancer treatment through the Calgary Prostate Institute rapid access clinic (RAC) and compare to historical data estimates in Alberta and to suggested standards. Biopsy rate, rate of confirmed prostate cancer and the distribution of treatment modality for patients seen through the RAC is included.
MATERIALS AND METHODS: A non-consented, retrospective chart review of 1103 patients from the Calgary Health Region referred to the RAC between September 2005 and August 2006 was completed.
RESULTS: Patients experienced a median wait time of 21 days between referral from their family doctor and prostate biopsy. A total of 31.4% of patients referred to the clinic were requested to have a prostate biopsy performed and 50.8% of biopsies resulted in confirmed prostate cancer requiring treatment. Median wait time between diagnosis and treatment for all treatment types was 52.0 days with a 90th percentile of 146.2 days. Median wait time between referral and treatment for all treatment modalities was 101 days with a 90th percentile of 187.2 days.
CONCLUSION: Calgary rapid access clinic reduces wait time between referral and biopsy by 78%. Stratifying across treatment type indicates that watchful waiting is the shortest time duration and radiation with hormone therapy is the longest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405444

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  7 in total

Review 1.  The interface of primary and oncology specialty care: from symptoms to diagnosis.

Authors:  Larissa Nekhlyudov; Steven Latosinsky
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).

Authors:  F O'Kelly; A Z Thomas; D Murray; P Lee; R F O'Carroll; P Nicholson; H Forristal; N Swan; D Galvin; D Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2013-02-17       Impact factor: 1.568

3.  A rapid access diagnostic clinic for prostate cancer: the experience after one year.

Authors:  J C Forde; K M O'Connor; L Casey; M O'Brien; S Bowen; R G Casey; I Ahmed; T E McDermott; R Grainger; T H Lynch
Journal:  Ir J Med Sci       Date:  2011-02-04       Impact factor: 1.568

4.  Wait times in prostate cancer diagnosis and radiation treatment.

Authors:  Christiaan Stevens; Susan J Bondy; D Andrew Loblaw
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

5.  Waiting Times for Prostate Cancer Diagnosis in a Nigerian Population.

Authors:  Olufunmilade A Omisanjo; Olawale O Ogunremi; Olufemi O Akinola; Olaolu O Adebayo; Olufemi Ojewuyi; Mofeyisayo O Omorinde; Abimbola A Abolarinwa; Stephen O Ikuerowo; Fatai A Balogun
Journal:  J Cancer Epidemiol       Date:  2021-08-16

6.  Audit of rapid access introduction reveals high prevalence of prostate cancer in Western Region.

Authors:  E M Bolton; B D Kelly; M R Quinlan; F T D'Arcy; M Azar; C M Dowling; M Power; P McCarthy; C Roche; K Walsh; E Rogers; G C Durkan
Journal:  Ir J Med Sci       Date:  2013-07-19       Impact factor: 1.568

Review 7.  Barriers to accessing radiation therapy in Canada: a systematic review.

Authors:  Caitlin Gillan; Kaleigh Briggs; Alejandro Goytisolo Pazos; Melanie Maurus; Nicole Harnett; Pamela Catton; David Wiljer
Journal:  Radiat Oncol       Date:  2012-10-12       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.